13G INITIAL MONTHLY FILING - ALRN

Company

Rein Therapeutics, Inc.

Filed

April 9, 2019

Accession Number

0000053417-19-000081

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →